Search results
Results from the WOW.Com Content Network
Fournier gangrene is a type of necrotizing fasciitis or gangrene affecting the external genitalia or perineum. It commonly occurs in older men, but it can also occur both in women and children and in people with diabetes or alcoholism or those who are immunocompromised.
Necrotizing fasciitis (NF), also known as flesh-eating disease, is an infection that kills the body's soft tissue. [3] It is a serious disease that begins and spreads quickly. [ 3 ] Symptoms include red or purple or black skin, swelling, severe pain, fever , and vomiting. [ 3 ]
Necrotizing fasciitis [1] Compartment syndrome [2] Mesenteric ischemia [3] Mueller-Weiss disease [4] Also used in reference to the medical diagnosis of Malingering ICD-10 Z76.5 as in "Pain out of proportion to symptoms". [5]
Fasciitis is an inflammation of the fascia, [1] which is the connective tissue surrounding muscles, blood vessels and nerves. In particular, it often involves one of the following diseases: Necrotizing fasciitis
The bacteria, which causes necrotizing fasciitis, has an extremely high mortality rate, and accurate diagnosis, rapid antibiotic administration and prompt surgery are extremely important in ...
Toxic shock syndrome (TSS) is a condition caused by bacterial toxins. [1] Symptoms may include fever, rash, skin peeling, and low blood pressure. [1] There may also be symptoms related to the specific underlying infection such as mastitis, osteomyelitis, necrotising fasciitis, or pneumonia.
Necrotizing fasciitis caused by an unknown bacterium which causes massive hemorrhaging and tissue necrosis. The first symptom of the disease is usually a painful rash, which develops into a scabby or weeping wound. In later stages, tissues become soft and slough away.
Many conditions mimic or may be mistaken for warfarin necrosis, including pyoderma gangrenosum or necrotizing fasciitis. Warfarin necrosis is also different from another drug eruption associated with warfarin, purple toe syndrome, which usually occurs three to eight weeks after the start of anticoagulation therapy. No report has described this ...